CpG Oligonucleotides Activate the Immune Response in Burned Mice

被引:1
|
作者
Yabuki, Teru [1 ]
Takeyama, Naoshi [2 ]
Tsuda, Masanobu [1 ]
Saitoh, Fukuki [1 ]
Tanaka, Takaya [3 ]
Noguchi, Hiroshi [2 ]
Nakatani, Toshio [1 ]
机构
[1] Kansai Med Univ, Dept Emergency & Crit Care Med, Osaka 5700074, Japan
[2] Aichi Med Univ, Dept Emergency & Crit Care Med, Aichi, Japan
[3] Handa City Hosp, Emergency Care Unit, Aichi, Japan
基金
日本学术振兴会;
关键词
burn injury; MHC class II expression; interleukin-12; interleukin-1; tumor necrosis factor-alpha; interleukin-6; immunoparalysis; CpG oligodeoxynucleotides; ESCHERICHIA-COLI INFECTIONS; COLONY-STIMULATING FACTOR; ANTIGEN-DR EXPRESSION; NECROSIS-FACTOR-ALPHA; INTERFERON-GAMMA; BACTERIAL-DNA; IFN-GAMMA; MACROPHAGES; PROTECTION; RESISTANCE;
D O I
10.1016/j.jss.2009.01.033
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Immunosuppression after burn injury increases the risk of sepsis and multiple organ failure. We examined changes of immune function in mice after burn injury and investigated the immunostimulatory effect of oligodeoxynucleotides containing CpG motifs. Materials and Methods. Male BALB/c mice (8-10 wk old) received a full-thickness burn to 20% of their body surface area, after which the immunological parameters of splenic macrophages were evaluated. To assess the immunostimulatory effect of oligodeoxynucleotide treatment, splenic macrophages harvested from burned mice were incubated with oligodeoxynucleotides. Then cytokine production and major histocompatibility complex class H antigen expression were measured. To assess the in vivo effect of oligodeoxynucleotides, intraperitoneal administration was done on day 4 after burn injury, and class II antigen expression by splenic macrophages was measured 10 d later. Results. Class II antigen expression and the synthesis of cytokines (interleukin-12, tumor necrosis factor-alpha, interleukin-6, and interleukin-1) by splenic macrophages were significantly reduced after burn injury, while incubation of splenic macrophages from burned mice with oligodeoxynucleotides partially enhanced the production of interleukin-12, tumor necrosis factor-a, interleukin-6, and interleukin-1. In addition, intraperitoneal administration of oligodeoxynucleotides enhanced class II antigen expression by splenic macrophages. Conclusions. The reduction of class II antigen expression and synthesis of cytokines (interleukin-12, tumor necrosis factor-a, interleukin-6, and interleukin-1) by splenic macrophages after burn injury was partially reversed by oligodeoxynucleotide treatment. Therefore, immunostimulatory oligodeoxynucleotides may be a potential treatment for post-burn immunosuppression. (C) 2010 Elsevier Inc. All rights reserved
引用
收藏
页码:111 / 118
页数:8
相关论文
共 50 条
  • [21] Inhibitory CpG oligonucleotides specifically block effects of stimulators CpG oligonucleotides in B cells
    Ashman, RF
    Stunz, LL
    Peckham, DW
    Haxhinasto, S
    Krieg, AM
    FASEB JOURNAL, 2000, 14 (06): : A963 - A963
  • [22] Prophylactic vaccines mimic synthetic CpG oligonucleotides in their ability to modulate immune responses
    de Vries, I. Jolanda M.
    Tel, Jurjen
    Benitez-Ribas, Daniel
    Torensma, Ruurd
    Figdor, Carl G.
    MOLECULAR IMMUNOLOGY, 2011, 48 (6-7) : 810 - 817
  • [23] Innate Immune Responses in Lupus-Prone Palmerston North Mice: Differential Responses to LPS and Bacterial DNA/CpG Oligonucleotides
    Petar Lenert
    Adam Goeken
    Barry S. Handwerger
    Robert F. Ashman
    Journal of Clinical Immunology, 2003, 23 : 202 - 213
  • [24] Innate immune responses in lupus-prone Palmerston North mice: Differential responses to LPS and bacterial DNA/CpG oligonucleotides
    Lenert, P
    Goeken, A
    Handwerger, BS
    Ashman, RF
    JOURNAL OF CLINICAL IMMUNOLOGY, 2003, 23 (03) : 202 - 213
  • [25] Inhibitory CpG oligonucleotides.
    Ashman, RF
    Yi, AK
    Peckham, DW
    Stunz, LL
    Krieg, AM
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S382 - S382
  • [26] Protection of Balb/c mice against infection with FMDV by immunostimulation with CpG oligonucleotides
    Kamstrup, Soren
    Frimann, Tine Holland
    Barfoed, Annette Malene
    ANTIVIRAL RESEARCH, 2006, 72 (01) : 42 - 48
  • [27] CpG-DNA as immune response modifier
    Dalpke, AH
    Heeg, K
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2004, 294 (05) : 345 - 354
  • [28] Gene expression profiling of immune cells exposed to immunostimulatory CpG oligonucleotides in vivo.
    Silver, JS
    Liu, Y
    Balasa, B
    CLINICAL IMMUNOLOGY, 2002, 103 (03) : S144 - S144
  • [29] B cells are responsible for defective response of lupus prone Palmerston-North mice to bacterial DNA/CpG-oligonucleotides
    Lenert, P
    Goeken, A
    Handwerger, BS
    Ashman, RF
    FASEB JOURNAL, 2003, 17 (07): : C186 - C186
  • [30] The counter regulatory response induced by CpG oligonucleotides prevents bleomycin induced pneumopathy
    Takeshi Kinjo
    Koji Tomaru
    Diana C Haines
    Dennis M Klinman
    Respiratory Research, 13